Diego Prost: The outcome with different agents in recurrent or advanced salivary cancer patients

Diego Prost, Medical oncologist and Neuro-oncology fellow at Pitié-Salpêtrière University Hospital, shared a post on X:

”Systemic treatments in recurrent or metastatic salivary gland cancer: a systematic review – ESMO Open.

Better outcomes are associated with histology, treatment response, and targeted therapy.

Proud to collaborate with Hospital Saint-Joseph and The National Cancer Institute of Milan.”

Systemic treatments in recurrent or metastatic salivary gland cancer: a systematic review

Authors: D. Prost, S. Iseas, M. Gatineau, J. Adam, S. Cavalieri, C. Bergamini, L. Licitra, É. Raymond.

Source: Diego Prost/X